The correlations between alteration of p16 gene and clinicopathological factors and prognosis in squamous cell carcinomas of the buccal mucosa

Journal of Oral Pathology and Medicine

Volumn 41, Issue 6, 2012, Pages 463-469

  Dong, Yuying ^a   Wang, Jie ^a,b   Dong, Fusheng ^a   Wang, Xu ^a   Zhang, Yinghuai ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b Key Laboratory of Stomatology   (China)

Author keywords

Buccal mucosa; Homozygous deletion; Methylation; P16 gene; Point mutation; Squamous cell carcinoma; Survival rate

Indexed keywords

PROTEIN P16;

ADULT; AGED; ARTICLE; BUCCAL MUCOSA SQUAMOUS CELL CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FISHER EXACT TEST; GENE DELETION; GENE MUTATION; HUMAN; KAPLAN MEIER METHOD; LOG RANK TEST; MALE; METHYLATION; MOUTH CARCINOMA; PATHOLOGY; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; TUMOR VOLUME;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CELL NUCLEUS; CYTOPLASM; DNA METHYLATION; EXONS; FEMALE; FOLLOW-UP STUDIES; GENE DELETION; GENES, P16; HOMOZYGOTE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; NEOPLASM STAGING; POINT MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROGNOSIS; PROMOTER REGIONS, GENETIC; SEQUENCE ANALYSIS, DNA; SURVIVAL RATE;

EID: 84863424417     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2012.01132.x     Document Type: Article

References (36)

1. Sailasree R, Abhilash A, Sathyan KM, Nalinakumari KR, Thomas S, Kannan S. Differential roles of p16INK4A and p14ARF genes in prognosis of oral carcinoma. Cancer Epidemiol Biomarkers Prev 2008; 17: 414-20.
2. Silverman S Jr. Demographics and occurrence of oral and pharyngeal cancers. The outcomes, the trends, the challenge. J Am Dent Assoc 2001; 132: 7-11.
3. Ries LA, Eisner MP, Kosary CL, et al. SEER cancer statistics review, 1975-2000. Bethesda, (MD): National Cancer Institute, 2003.
4. Ahmed SM, Mubeen K, Jigna VR. Molecular biology: an early detector of oral cancers. Ann Diagn Pathol 2009; 13: 140-5.
5. Yuen PW, Man M, Lam KY, Kwong YL. Clinicopathological significance of p16 gene expression in the surgical treatment of head and neck squamous cell carcinomas. J Clin Pathol 2002; 55: 58-60.
6. Jang SJ. Cell cycle regulators as prognostic predictor of colorectal cancers. Korean J Gastroenterol 2004; 44: 346-9.
7. Rocco JW, Sidransky D. p16(MTS-1/CDKN2/INK4a) in cancer progression. Exp Cell Res 2001; 264: 42-55.
8. Kim HS, Chung WB, Hong SH, et al. Inactivation of p16INK4a in primary tumors and cell lines of head and neck squamous cell carcinoma. Mol Cells 2000; 10: 557-65.
9. Muirhead DM, Hoffman HT, Robinson RA. Correlation of clinicopathological features with immunohistochemical expression of cell cycle regulatory proteins p16 and retinoblastoma: distinct association with keratinisation and differentiation in oral cavity squamous cell carcinoma. J Clin Pathol 2006; 59: 711-5.
10. Ohta S, Uemura H, Matsui Y, et al. Alterations of p16 and p14ARF genes and their 9p21 locus in oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009; 107: 81-91.
11. Tsai CH, Yang CC, Chou LS, Chou MY. The correlation between alteration of p16 gene and clinical status in oral squamous cell carcinoma. J Oral Pathol Med 2001; 30: 527-31.
12. Lin SC, Chang KW, Chang CS, et al. Alterations of p16/MTS1 gene in oral squamous cell carcinomas from Taiwanese. J Oral Pathol Med 2000; 29: 159-66.
13. Lee JK, Kim MJ, Hong SP, Hong SD. Inactivation patterns of p16/INK4A in oral squamous cell carcinomas. Exp Mol Med 2004; 36: 165-71.
14. Tadokoro H, Shigihara T, Ikeda T, Takase M, Suyama M. Two distinct pathways of p16 gene inactivation in gallbladder cancer. World J Gastroenterol 2007; 13: 6396-403.
15. Attri J, Srinivasan R, Majumdar S, Radotra BD, Wig J. Alterations of tumor suppressor gene p16INK4a in pancreatic ductal carcinoma. BMC Gastroenterol 2005; 5: 22.
16. Ding Y, Le XP, Zhang QX, Du P. Methylation and mutation analysis of p16 gene in gastric cancer. World J Gastroenterol 2003; 9: 423-6.
17. Tokugawa T, Sugihara H, Tani T, Hattori T. Modes of silencing of p16 in development of esophageal squamous cell carcinoma. Cancer Res 2002; 62: 4938-44.
18. O'Regan EM, Toner ME, Finn SP, et al. p16(INK4A) genetic and epigenetic profiles differ in relation to age and site in head and neck squamous cell carcinomas. Hum Pathol 2008; 39: 452-8.
19. Shintani S, Nakahara Y, Mihara M, Ueyama Y, Matsumura T. Inactivation of the p14(ARF), p15(INK4B) and p16(INK4A) genes is a frequent event in human oral squamous cell carcinomas. Oral Oncol 2001; 37: 498-504.
20. Pande P, Mathur M, Shukla NK, Ralhan R. Alter 6pRb and p16 protein alterations in human oral tumorigenesis. Oral Oncol 1998; 34: 396-403.
21. Gologan O, Barnes EL, Hunt JL. Potential diagnostic use of p16INK4A, a new marker that correlates with dysplasia in oral squamoproliferative lesions. Am J Surg Pathol 2005; 29: 792-6.
22. Vairaktaris E, Yapijakis C, Psyrri A, et al. Loss of tumour suppressor p16 expression in initial stages of oral oncogenesis. Anticancer Res 2007; 27: 979-84.
23. Buajeeb W, Poomsawat S, Punyasingh J, Sanguansin S. Expression of p16 in oral cancer and premalignant lesions. J Oral Pathol Med 2009; 38: 104-8.
24. Lang JC, Borchers J, Danahey D, et al. BMutational status of overexpressed p16 in head and neck cancer: evidence for germline mutation of p16/p14ARF. Int J Oncol 2002; 21: 401-8.
25. Semczuk A, Boltze C, Marzec B, Szczygielska A, Roessner A, Schneider-Stock R. P16INK4A alterations are accompanied by aberrant protein immunostaining in endometrial carcinomas. J Cancer Res Clin Oncol 2003; 129: 589-96.
26. Orlow I, LaRue H, Osman I, et al. Deletions of the INK4A gene in superficial bladder tumors. Association with recurrence. Am J Pathol 1999; 155: 105-13.
27. Spathis A, Aga E, Alepaki M, et al. Promoter methylation of p16(INK4A), hMLH1, and MGMT in liquid-based cervical cytology samples compared with clinicopathological findings and HPV presence. Infect Dis Obstet Gynecol 2011; 2011: 927861.
28. Yakushiji T, Noma H, Shibahara T, et al. Analysis of a role for p16/CDKN2 expression and methylation patterns in human oral squamous cell carcinoma. Bull Tokyo Dent Coll 2001; 42: 159-68.
29. Goto T, Mizukami H, Shirahata A, et al. Methylation of the p16 gene is frequently detected in lymphatic-invasive gastric cancer. Anticancer Res 2010; 30: 2701-3.
30. Ignatov A, Bischoff J, Schwarzenau C, et al. P16 alterations increase the metastatic potential of endometrial carcinoma. Gynecol Oncol 2008; 111: 365-71.
31. Koscielny S, Dahse R, Ernst G, von Eggeling F. The prognostic relevance of p16 inactivation in head and neck cancer. ORL J Otorhinolaryngol Relat Spec 2007; 69: 30-6.
32. Supic G, Kozomara R, Jovic N, Zeljic K, Magic Z. Prognostic significance of tumor-related genes hypermethylation detected in cancer-free surgical margins of oral squamous cell carcinomas. Oral Oncol 2011; 47: 702-8.
33. Uzawa N, Sonoda I, Myo K, Takahashi K, Miyamoto R, Amagasa T. Fluorescence in situ hybridization for detecting genomic alterations of cyclin D1 and p16 in oral squamous cell carcinomas. Cancer 2007; 110: 2230-9.
34. Cao J, Zhou J, Gao Y, et al. Methylation of p16 CpG island associated with malignant progression of oral epithelial dysplasia: a prospective cohort study. Clin Cancer Res 2009; 15: 5178-83.
35. Bazan V, Zanna I, Migliavacca M, et al. Prognostic significance of p16INK4a alterations and 9p21 loss of heterozygosity in locally advanced laryngeal squamous cell carcinoma. J Cell Physiol 2002; 192: 286-93.
36. Su PF, Huang WL, Wu HT, Wu CH, Liu TY, Kao SY. p16(INK4A) promoter hypermethylation is associated with invasiveness and prognosis of oral squamous cell carcinoma in an age-dependent manner. Oral Oncol 2010; 46: 734-9.